GlassScriptPhysician profile
Adam T Smith
NPI 1730210444
$2,340.13
in general payments reported to CMS, 2019-2025
23 companies · $391 in 2025
The $391 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $445 · 2021: $77.64 · 2022: $157 · 2023: $353 · 2024: $492 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,147 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,146.89 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $558.73 | 2019-2023 | Orilissa, Liletta, Lo Loestrin Fe |
| Bayer Healthcare Pharmaceuticals INC. | $282.61 | 2019-2025 | |
| Sage Therapeutics, LLC | $204.46 | 2024-2025 | Zurzuvae |
| Organon LLC | $185.41 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $183.91 | 2022-2025 | Slynd |
| Astellas Pharma US INC | $181.72 | 2020-2025 | Veozah |
| Intuitive Surgical, INC. | $106.14 | 2020-2025 | |
| Shield Therapeutics INC | $75.62 | 2024 | |
| Therapeuticsmd, INC. | $70.35 | 2019 | |
| Hologic Sales and Service, LLC | $63.87 | 2021-2025 | Aptima, Thinprep 2000 Processor |
| Minerva Surgical, INC | $51.20 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $50.62 | 2019-2025 | Gardasil 9 |
| Glaxosmithkline, LLC. | $45.90 | 2019-2020 | |
| Sanofi Pasteur INC. | $36.83 | 2021-2025 | |
| Amag Pharmaceuticals, INC. | $35.19 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $34.62 | 2024 | Vistaseal, Harmonic |
| Pfizer INC. | $33.09 | 2024-2025 | |
| Coopersurgical, INC. | $32.80 | 2022-2024 | Paragard T 380a |
| Covidien LP | $27.02 | 2019 | |
| Mimedx Group, INC. | $24.58 | 2025 | |
| Avanos Medical | $24.13 | 2019 | |
| Convatec INC. | $19.38 | 2025 | |
| Phadia US INC. | $11.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.